🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Guoqiao Wang

Washington University in St. Louis

ORCID: 0000-0002-6808-8737
MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial”.

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

The Lancet Neurology(2025)10.1016/s1474-4422(25)00024-9
N/A
1.2DataRank · unranked
41 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +62 more

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2024)10.1001/jamaneurol.2024.0991
N/A
1.0DataRank · unranked
29 citations

Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Marzia A. Scelsi +94 more

Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae159
N/A
0DataRank · unranked
10 citations

Jorge J. Llibre‐Guerra, Eric McDade, Lauren Edwards, Brian A. Gordon, Tammie L.S. Benzinger +32 more

The CentiMarker project: Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation

Alzheimer s & Dementia(2025)10.1002/alz.14587
N/A
0DataRank · unranked
6 citations

Yan Li, Chengjie Xiong, Yuchen Cao, Suzanne E. Schindler, Eric McDade +13 more

Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations

Alzheimer s & Dementia(2025)10.1002/alz.70643
N/A
0DataRank · unranked
1 citations

Yan Li, Eric McDade, Chengjie Xiong, Sarah M. Hartz, Randall J. Bateman +4 more

Clinical Progression on CDR-SB © : Progression Free Time at Each 0.5-unit Level in Dominantly Inherited and Sporadic Alzheimer’s Disease Populations

medRxiv(2025)10.1101/2025.02.17.25322322
N/A
0DataRank · unranked
0 citations

Yan Li, Eric McDade, Chengjie Xiong, Sarah M. Hartz, Randall J. Bateman +3 more